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Nipah virus (NiV) is a highly pathogenic paramyxovirus 
that causes fatal encephalitis in humans. The initial outbreak 
of NiV infection occurred in Malaysia and Singapore in 
1998–1999; relatively small, sporadic outbreaks among 
humans have occurred in Bangladesh since 2001. We 
characterized the complete genomic sequences of identical 
NiV isolates from 2 patients in 2008 and partial genomic 
sequences of throat swab samples from 3 patients in 
2010, all from Bangladesh. All sequences from patients in 
Bangladesh comprised a distinct genetic group. However, 
the detection of 3 genetically distinct sequences from 
patients in the districts of Faridpur and Gopalganj indicated 
multiple co-circulating lineages in a localized region over a 
short time (January–March 2010). Sequence comparisons 
between the open reading frames of all available NiV genes 
led us to propose a standardized protocol for genotyping 
NiV; this protcol provides a simple and accurate way to 
classify current and future NiV sequences.
N
ipah virus (NiV) is a deadly paramyxovirus that was 
ﬁ   rst described during 1998–1999 in Malaysia and 
Singapore, when a large epidemic of fatal encephalitis 
occurred in humans (283 cases, 109 deaths) (1). In this 
initial outbreak, most human cases were epidemiologically 
linked with activities involving close contact with sick pigs; 
the outbreak ended after >1 million pigs were culled and 
movement of pigs was stopped (2). Although NiV infection 
has not been detected in Malaysia or Singapore since 1999, 
NiV has caused recurring (almost annual) outbreaks of 
fatal encephalitis in Bangladesh and sporadic outbreaks 
in India since 2001 (3–6). The outbreaks in Bangladesh 
have demonstrated human-to-human and foodborne 
transmission of NiV (7–9). Although the outbreaks in 
Bangladesh have been smaller, the case-fatality rates have 
been consistently higher (≈75%) than those from the initial 
outbreak in Malaysia and Singapore (≈40%) (8,10). The 
clinical case deﬁ  nition used in Bangladesh differs from that 
used during the Malaysia outbreak and focuses on fatal or 
severe neurologic signs and symptoms. Sequence analysis 
of virus isolates and clinical samples obtained from persons 
affected by the outbreaks in Bangladesh and India indicated 
greater nucleotide heterogeneity than those from Malaysia 
(3,4,11).
Within 2 weeks in Bangladesh during February 2008, 
2 clusters of human NiV infection resulted in 10 cases 
with 9 deaths (90% case-fatality rate). The locations of 
the clusters (Rajbari and Manikgonj districts) were ≈44 
km apart, separated by the intersection of the Padma and 
Jamuna Rivers. The outbreak was linked to ingestion of 
raw date palm sap (12). From December 2009 through 
March 2010, an outbreak of NiV infection in Fardipur and 
Gopalganj districts was responsible for 17 cases and 15 
deaths (88% case-fatality rate) (6). 
In this study, we conﬁ  rmed the suspected clinical cases 
of NiV infection from both outbreaks by using IgM and IgG 
ELISAs, real-time and conventional reverse transcription 
PCR (RT-PCR), and virus isolation. We characterized the 
complete genomic sequences of 2 identical NiV isolates 
from 2008 and 3 partial genomic sequences of isolates 
from 2010. Our results indicate the presence of multiple 
co-circulating lineages of NiV in a localized region over a 
short time in 2010. Phylogenetic and sequence analysis of 
Characterization of Nipah Virus 
from Outbreaks in Bangladesh, 
2008–2010
Michael K. Lo, Luis Lowe, Kimberly B. Hummel, Hossain M.S. Sazzad, Emily S. Gurley, 
M. Jahangir Hossain, Stephen P. Luby, David M. Miller, James A. Comer, Pierre E. Rollin, 
William J. Bellini,  and Paul A. Rota
RESEARCH
248  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 2, February 2012
Author afﬁ   liations: Centers for Disease Control and Prevention, 
Atlanta, Georgia, USA (M.K. Lo, L. Lowe, K.B. Hummel, D.M. Miller, 
J.A. Comer, P.E. Rollin, W.J. Bellini, P.A. Rota); and International 
Centre for Diarrheal Disease Research, Bangladesh, Dhaka, 
Bangladesh (H.M.S. Sazzad, E.S. Gurley, M.J. Hossain, S.P. Luby)
DOI: http://dx.doi.org/10.3201/eid1802.111492Characterization of Nipah Virus, Bangladesh
all currently available full-length NiV gene open reading 
frames (ORFs) led us to propose a standardized protocol 
for genotyping NiV.
Methods
Sample Collection and Case Deﬁ  nition
We collected blood, cerebrospinal ﬂ  uid (CSF), urine, 
and throat swab samples from patients with suspected 
cases. The serum and CSF samples were separated into 
aliquots locally, and all specimens were transported to 
the International Centre for Diarrheal Disease Research, 
Bangladesh (ICDDR,B) in cold packs or in liquid nitrogen 
for subsequent storage at −70°C. Serum and CSF samples 
were initially tested for IgM against NiV at ICDDR,B 
and then sent to the Centers for Disease Control and 
Prevention (CDC) (Atlanta, GA, USA) for conﬁ  rmatory 
testing. Samples were conﬁ  rmed as NiV positive if IgM 
against NiV was found in serum or CSF; if NiV RNA was 
ampliﬁ  ed; or if NiV was isolated from CSF, urine, or throat 
swab samples (6,12). 
Serologic Testing
 Serum samples were tested at ICDDR,B for IgM against 
NiV by ELISA as described (1,3,13). At CDC, samples 
were irradiated with gamma rays before conﬁ  rmatory 
testing for IgM and IgG against NiV as described (3).
Detection of NiV by Real-Time, Conventional RT-PCR, 
and Virus Isolation
Virus isolation was attempted on Vero E6 cells as 
described (1). Human urine, CSF, and oropharyngeal 
swab samples were inactivated in guanidine isothiocynate 
(GITC) at a dilution of 1 part sample to 5 parts GITC. 
RNA was extracted by the acid GITC–phenol–chloroform 
method (14). Real-time RT-PCR (rRT-PCR) was 
performed by using the following primers that ampliﬁ  ed 
a 112-nt fragment spanning from positions 538 to 650 in 
the NiV N gene: forward primer NVBNF2B 5′-CTGG
TCTCTGCAGTTATCACCATCGA-3′, reverse primer 
NVBN593R 5′-ACGTACTTAGCCCATCTTCTAGTTT
CA-3′, and probe NVBN542P 5′-CAGCTCCCGACAC
TGCCGAGGAT-3′, with the FAM dye incorporated at 
the 5′ terminus and a BHQ1 quencher molecule at the 
3′ terminus. The rRT-PCR cycling conditions were as 
follows: 48°C for 30 min, 95°C for 10 min, and 45 cycles 
of 95°C for 15 s followed by 1 min at 60°C. Synthetic 
NiV N gene RNA was produced by in vitro transcription 
that used pTM1-N plasmid (15) with Megascript kit 
(Ambion, Austin, TX, USA) according to manufacturer’s 
instructions. An Applied Biosystems 7900HT machine 
was used for rRT-PCRs, and the PCR Core Kit along with 
MultiScribe Reverse Transcriptase were used for the rRT-
PCR master mix (all from Applied Biosystems, Foster 
City, CA, USA). Conventional RT-PCR was performed 
with the SuperScript One-Step RT-PCR kit with Platinum 
Taq (Invitrogen, Carlsbad, CA, USA) as described (11). 
Two-step RT-PCR was performed for selected samples 
by using SuperScript III First-Strand Synthesis System 
(Invitrogen) to generate cDNA and Platinum Taq DNA 
Polymerase High Fidelity (Invitrogen) for the PCR. Brieﬂ  y, 
8 μL of extracted RNA was used in a 20-μL RT reaction 
with a primer complementary to the 3′ leader NVB3END 
(5′-ACCAAACAAGGGAAAATATGGATACGTT-3′) 
and the 5′ trailer NIP5END (5′-ACCGAACAAGGG
TAAAGAAGAATCG-3′) sequences of the NiV genome 
from the 2004 Bangladesh outbreak (GenBank accession 
no. AY988601). Subsequently, 2 μL of the cDNA reaction 
was used in 50-μL PCRs to amplify the N, P, M, F, G, 
and L ORFs with corresponding primer sets that anneal 
to the noncoding regions for the respective genes: N ORF 
NVBN5NCF1 (5′-GGTCTTGGTATTGGATCCTC-3′) and 
NVBN3NCR1 (5′-GTTTAATCTAAGTTAAGATTG-3′); 
P ORF  NVBPPCRFW (5′-AGCAGTTATCAGCTGGG
AGTTCAACTTAC-3′) and NVBPPCRREV (5′-ATGC
GTGAATGAACTACAATACGAATCGAC-3′); M ORF
NVBMPCRFW (5′-TCCAATAACTGGTCAATTGAG
GACAGAAATCCTG-3′) and NVBMPCRREV (5′-CATA
ATAGTTGTCTAATTATTAACCGAATATTCAC-3′); 
F ORF  NVBPCRFFW (5′-CAAGCATTATTACTATCT
GATCAACAAAAGGATTGG-3′) and NVBPCRFREV 
(5′-GAATATCAACTGTTCATTCATGGTTGAGTAC-
3′); G ORF  NVBPCRGFW (5′-CAGGTCCATAACT
CATTGGATATTAAACTGTGTCC-3′) and NVBPCR
GREV (5′-CAAGATTTAGCTCTACTATATCAAATG
GAGTTTCAGTCAAG-3′); and L ORF (ampliﬁ  ed  in  2 
fragments)  NVBPCRL1FW (5′-CAGGTCCTTGATTGTG
CTAATTTTCTTGAG-3′) and FRAG4REV (5′-GAT
CTTATCAGGCCTTTAGTTGTATCTAATAGACC-3′), 
FRAG5FW (5′-TGAGGACCTTGAACTAGCTAGCTTC
CT-3′) and NVBLREV (5′-AATTGTCGGTCGGTTC
TGGACTTGGAAGATCAAATCAGATAATGGAT
ATG-3′). PCR products were analyzed by agarose gel 
electrophoresis with GelRed staining (Biotium, Hayward, 
CA, USA), gel puriﬁ  ed, and sequenced as described (3,11). 
Rapid ampliﬁ   cation of cDNA ends was performed by 
using the 5′ RACE Kit 2.0 (Invitrogen). Phylogenetic and 
molecular analyses of the sequences were performed by 
using MEGA5 (16).
Results
Of the 10 cases from the 2008 outbreak in Bangladesh, 
5 were conﬁ  rmed positive for NiV infection by at least 
1 laboratory test at CDC. Of those 5 positive cases, 4 
were positive for IgM; 2 for IgG; 3 by rRT-PCR; and 2 
by conventional RT-PCR; 2 throat swab samples yielded 
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live NiV, 1 from Manikgonj (NiV/BD/HU/2008/MA 
[BD, Bangladesh; HU, human]; accession no. JN808857) 
and 1 from Rajbari (NiV/BD/HU/2008/RA; accession no. 
JN808863) (Table 1). Despite the isolates having come from 
patients from 2 districts, sequence analysis of the entire 
genome of the 2 isolates indicated that they were identical. 
Phylogenetic analysis of ORFs from each NiV gene 
indicated that this strain was similar to, but distinct from, 
the 2007 isolate from India (NiV/IN/HU/2007/FG [IN, 
India]; accession no. FJ513078) (Figure 1, panel A; Figure 
2, panels A–E). To rule out the possibility of laboratory 
contamination, we performed 2-step conventional RT-PCR 
by using RNA from duplicate samples of the original throat 
swab samples from which the 2 viruses were isolated. We 
ampliﬁ  ed the entire N gene ORF from each sample and 
conﬁ   rmed that the sequences were identical. Although 
there were 4 isolated cases of NiV infection in Bangladesh 
in 2009 as conﬁ  rmed by IgM or IgG ELISA, or both, we 
were not able to obtain NiV sequences from those case-
patients (Table 1).
Of the 17 cases from the 2010 outbreak in Bangladesh, 
12 were conﬁ  rmed positive. All 12 were positive for IgM, 
2 for IgG, 5 by rRT-PCR, and 3 by conventional 2-step 
RT-PCR (Table 1). Although we detected NiV RNA by 
rRT-PCR from urine, CSF, and throat swab samples, we 
were unable to isolate virus from any of those sources. 
Of the 3 samples from which we were able to amplify 
NiV sequences, 1 was from a 10-year-old girl from the 
initial cluster (NiV/BD/HU/2010/FA2; accession no. 
JN808859) and the other 2 were from patients with 
isolated cases. The patients with isolated cases were a 
medical intern (NiV/BD/HU/2010/FA1; accession no. 
JN808864) who was working in the pediatric department 
at Faridpur Medical College Hospital and a 7-year-old 
girl (NiV/BD/HU/2010/GO; accession no. JN808860) 
who was examined by the same medical intern; both died. 
The illness developed in the intern only 6 days after the 
7-year-old girl died; this incubation period was atypically 
short for NiV infection, indicating the possibility of 
separate infections (6). Sequence analysis of the N ORFs 
ampliﬁ  ed from throat swab samples conﬁ  rmed that the 
intern and the girl were infected with distinct lineages 
of NiV (Figure 1, panel A). Our attempts to recover NiV 
sequences from prior contacts of the medical intern who 
were IgM positive for NiV infection were unsuccessful. 
Phylogenetic analysis indicated that the sequence from the 
7-year-old girl was similar to, but distinct from, the 2007 
isolate from India, whereas the sequence from the intern 
was closer to that of the 2004 isolate from Bangladesh 
(NiV/BD/HU/2004/RA1; accession no. AY988601). The 
N sequence obtained from the 10-year-old girl from the 
initial cluster was shown to be slightly more similar to 
the 2007 isolate from India (Figure 1, panel A). We were 
only able to amplify the complete N ORF from the throat 
swab samples from the 7-year-old and 10-year-old girls 
because our rRT-PCR indicated the presence of ≈103 to 
104 copies of NiV N RNA (cycle threshold ≈26–30). The 
rRT-PCR conducted on the throat swab sample from the 
medical intern indicated the presence of ≈106 copies of 
NiV N RNA (cycle threshold ≈20), which corroborated 
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Table 1. Results from patients with confirmed Nipah virus infection, Bangladesh, 2008–2010* 
Patient no.  Year isolated  Case type 
Serologic result  RT-PCR result 
Virus isolation  IgM IgG Conventional  Real-time 
1 2008  Cluster  +  +    – –  – 
2 2008  Cluster  +  –    – +  – 
3 2008  Cluster  –  –    + +  + 
4 2008  Cluster  +  –    + +  + 
5 2008  Cluster  +  +    – –  – 
6 2009  Isolated  +  +    NA  NA  NA 
7 2009  Isolated  +  –    NA  NA  NA 
8 2009  Isolated  +  –    NA  NA  NA 
9 2009  Isolated  +  –    NA  NA  NA 
10 2010  Cluster  +  –    NA  NA  NA 
11 2010  Cluster  +  –    +  +  – 
12 2010  Cluster  +  –    –  +  – 
13 2010  Cluster  +  –    NA  NA  NA 
14 2010  Cluster  +  +    NA  NA  NA 
15 2010  Isolated  +  –    –  +  – 
16 2010  Isolated  +  +    +  +  – 
17 2010  Isolated  +  –    +  +  – 
18 2010  Isolated  +  –    NA  NA  NA 
19 2010  Isolated  +  –    NA  NA  NA 
20 2010  Isolated  +  –    NA  NA  NA 
21 2010  Isolated  +  –    NA  NA  NA 
*RT-PCR, reverse transcription PCR; +, positive; –, negative; NA, sample not available. Characterization of Nipah Virus, Bangladesh
our ability to amplify nearly the entire genome except 
for the 3′ leader and 5′ trailer (data not shown) from this 
sample.
Since the initial molecular characterization of NiV 
from Bangladesh in 2004 (11), there has been a shortage 
of full-length NiV ORF sequences from Bangladesh. 
However, the sequence data obtained from the 2008 and 
2010 Bangladesh outbreaks in this study, along with the 
recent characterization of the 2007 isolate from India (4), 
support the previous observation of relative heterogeneity 
among NiV nucleotide sequences from humans affected 
by outbreaks in Bangladesh compared with sequences 
from Malaysia (11). Phylogenetic analysis indicated that 
these new sequences from Bangladesh and India group 
substantially closer to the sequences from Bangladesh in 
2004, which led us to propose a system to describe the 
distinct lineages of NiV (Figure 1; Figure 2, panels A–E). 
We propose to designate the current sequences obtained 
from Malaysia (MY) and Cambodia (KH) as genotype M 
and the sequences obtained from Bangladesh and India as 
genotype B. By using a 729-nt window in the N terminal 
region of the N gene ORF (N ORF nt 123–852, NiV genome 
positions 236–964), we were able to determine 25 distinct 
nucleotides that universally differentiated the genotypes 
(Figure 1, panel B). The topology of the phylogenetic 
tree and the positions of the branches generated from this 
smaller nucleotide window were similar to those of the 
tree generated with the full-length N ORF sequences and 
have reasonably high bootstrap values at the root branch 
junctions, albeit with lower bootstrap values at the distal 
branch junctions (Figure 1, panels A, B). In support of this 
scheme, we observed similar topologies and branching 
patterns in phylogenetic trees generated for the complete 
P, M, F, G, and L ORFs, all with strong bootstrap values 
(Figure 2, panels A–E).
Pairwise sequence comparisons conducted across each 
individual NiV gene ORF indicated a nucleotide variation 
range of 6.32%–9.15% between genotype M and B viruses 
and an amino acid variation range of 1.42%–9.87% (Table 2; 
online Technical Appendix, wwwnc.cdc.gov/EID/pdfs/11-
1492-Techapp.pdf). The ranges of nucleotide and amino 
acid variation of sequences within genotype M were 0.19%–
2.21% and 0.18–3.67%, respectively, and within genotype 
B were 0.28%–1.06% and 0.28% –0.56%, respectively. The 
apparently higher levels of variation found among ORFs 
within genotype M is mostly caused by the comparatively 
divergent sequences obtained from Pteropus vampyrus 
(NiV/MY/BA/2010/MY; accession no. FN869553) 
and  P. lylei (NiV/KH/BA/2004/KHM; accession nos. 
AY858110, AY858111) bats. Not only is the proposed 
genotyping scheme supported by consistent phylogenetic 
tree topologies, but pairwise nucleotide comparisons of 
the 729-nt region yield similar percentages of variability 
as seen in the full-length N ORF comparisons. This ﬁ  nding 
indicates that this sequence window is a relatively accurate 
indicator of overall nucleotide variability within and across 
genotypes M and B (online Technical Appendix Figure 1, 
panels A, C).
A comprehensive amino acid alignment of currently 
available complete N protein ORFs indicated that the 
4 residues that distinguish between genotype M and B 
viruses are almost all located in the COOH-terminus 
(Table 3). Of these residues, only 1 (position 387) is located 
within the putative minimum contiguous sequence required 
for capsid assembly (17), and none were located in the 29 
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Figure 1. Phylogenetic analyses of sequences from the complete 
Nipah virus N ORF (A) and the 729-nt proposed N ORF genotyping 
window (B). Tree created with maximum parsimony, close-
neighbor-interchange algorithm, 1,000 bootstrap replicates (16). 
Branch lengths are in units of number of changes over the whole 
sequence. Available GenBank accession numbers are shown 
for corresponding sequences. Proposed genotype groupings 
are indicated by brackets (M, B). ORF, open reading frame; MY, 
Malaysia; KH, Cambodia; BD, Bangladesh; IN, India; HU, human; 
PI, pig; BA, bat. Scale bars indicate number of sequence changes 
corresponding to illustrated branch length.RESEARCH
COOH-terminal and 10 NH-terminal residues required for 
interaction with the P protein (18,19). Of note, there are 
4 residues (V429, E432, D457, and T521) in the COOH-
terminal region common to all genotype B sequences that 
are shared with 2 of the comparatively divergent genotype M 
sequences. In light of the overall nucleotide and amino acid 
sequence comparisons, however, the divergent genotype 
M sequences from the bats still differ substantially from 
genotype B sequences (Figure 1, panel A; Figure 2, panels 
A–E; online Technical Appendix Figure 1, panels A, B).
Amino acid alignments of the P protein indicated 
numerous differences between genotype M and B 
sequences in the ﬁ   rst 400 residues, which comprise 
the shared N terminal region between the P, V, and W 
proteins. Of the differences in this region, there were 
neither changes that would be predicted to alter the STAT-
1 binding ability of the P, V, and W proteins nor changes 
that could adversely affect RNA replication (20–22). There 
were only 4 changes in the COOH-terminal region of P, 
which is required for direct N–P interactions, 2 of which 
were nonconservative changes (N590→S, E635→G) (18). 
The P sequence derived from P. vampyrus bats had an 
intriguing sequence of amino acids from residues 408–440, 
in which there was substantial sequence divergence from 
genotypes M and B at the nucleotide and amino acid levels 
(23). These particular nucleotide changes in the P sequence 
also introduced several amino acid changes in the unique 
COOH-terminal regions of the V (11 changes) and W (9 
changes) ORFs, which distinguish them from any genotype 
M and B sequences.
We observed the M protein to be highly conserved 
across genotypes M and B, and we found just 2 aa residues 
exclusive to genotype B that are not located in any region 
of the protein with a known function, such as budding 
(24,25), nuclear localization, or ubiquitination (26). In the 
F protein, the predicted cleavage site, F1 amino-terminal 
domain, transmembrane domain, and predicted N-linked 
glycosylation sites are all conserved across both genotypes. 
Although the percentage of amino acid variation in the G 
protein is higher than that in all other NiV proteins (except 
the P protein), it is not surprising that the residues implicated 
in Ephrin B2 and B3 binding are conserved across the 
genotypes (27,28). The amino acid differences between 
genotypes M and B sequences are predominantly found 
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Figure 2. Phylogenetic analyses of sequences from the complete Nipah virus P ORF (A), M ORF (B), F ORF (C), G ORF (D), and L ORF 
(E). Tree created with maximum parsimony, close-neighbor-interchange algorithm, 1,000 bootstrap replicates (16). Branch lengths are in 
units of number of changes over the whole sequence. Available GenBank accession numbers are shown for corresponding sequences. 
Proposed genotype groupings are indicated by brackets (M, B). ORF, open reading frame; MY, Malaysia; KH, Cambodia; BD, Bangladesh; 
IN, India; HU, human; PI, pig; BA, bat. Scale bars indicate number of sequence changes corresponding to illustrated branch length.
Table 2. Percentage nucleotide and amino acid variability among available complete Nipah virus open reading frame sequences 
Gene 
Open reading frame 
length, nt/aa 
% nt variation  % aa variation 
Overall   Genotype M  Genotype B  Overall   Genotype M  Genotype B 
N  1,599/532  0.0–6.32 0.0–2.19  0.0–1.06    0.0–2.26 0.0–1.69  0.0–0.56 
P  2,130/709  0.0–9.15 0.0–2.21  0.0–0.99    0.0–9.87 0.0–3.67  0.0–0.99 
M  1,059/352  0.0–6.70 0.0–0.57  0.0–0.28    0.0–1.42 0.0–0.85  0.0–0.28 
F  1,641/546  0.0–6.76 0.0–0.85  0.0–0.98    0.0–1.65 0.0–0.75  0.0–0.55 
G  1,809/602  0.0–7.35 0.0–1.93  0.0–0.55    0.0–4.65 0.0–1.83  0.0–0.33 
L 6,735/2244  0.0–6.68  0.01–0.19  0.0–0.82    0.0–1.92  0.0–0.18  0.0–0.45 Characterization of Nipah Virus, Bangladesh
at residues that are distant from the receptor binding site. 
Two differences were found in the intracellular domain, 
3 differences in the stalk region (positions 72–182), 9 
differences in a span of ≈100 aa (positions 236–344) along 
the side of the globular head domain, 4 differences closer 
to the top of the globular head domain (positions 385–424), 
and only 2 differences (positions 498 and 502) that were 
close to the tryptophan residue at position 504, which is part 
of the receptor-binding pocket. As in other NiV proteins, 
several amino acids were shared between genotype B 
sequences and 2 genotype M sequences derived from the 
bat isolates. The signiﬁ  cance of these changes has yet to 
be explored.
The level of amino acid conservation throughout the 
L proteins was high; the purported GDNE catalytic site 
and the K-X21-GEGSG ATP binding site were conserved 
across genotypes M and B. Most distinct differences 
between genotypes M and B sequences (26 of 32) were 
located outside the 6 linear domains typically found in 
nonsegmented negative strand virus polymerases (29,30). 
The cis-acting control sequences in NiV are usually 
well conserved. The tri-nucleotide intergenic sequences 
ampliﬁ  ed from the throat swab sample from the medical 
intern in 2010 had GAA for all 6 intergenic regions, which 
was identical to the 2007 isolate from India. For the 2008 
isolates, the intergenic sequence between the N and P 
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Table 3. Amino acid differences among available complete Nipah virus N gene open reading frame sequences* 
Sequence and 
accession  no. 
Amino acid position 
G  30 139 188 211 318 345 380 381 387 414 429 432 436 457 502 505 506 508 511 518 521
NiV/MY/HU/1999/CDC, 
AF212302 
M  T S E Q I M N R D K  I G I  N  I  R T G E L A 
NiV/MY/PI/1999/1413, 
AJ564622
M  . . . . . . . . . . . . . . . . . . . . . 
NiV/MY/PI/1999/2794, 
AJ564621
M  . . . . . . . . . . . . . . . . . . . . . 
NiV/MY/PI/1999/0626, 
AJ627196
M  .  R  . . . I . . . . . . . . . . . . . . . 
NiV/MY/HU/1999/0128, 
AJ564623
M  . . . . . . . . . . . . . . . . . . . . . 
NiV/MY/HU/1999/UM1, 
AY029767 
M  . . . . . . . . . . . . . . . . . . . . . 
NiV/MY/HU/1999/UM2, 
AY029768 
M  . . . . . . . . . . . . . . . . . . . . . 
NiV/MY/BA/2000/TI, 
AF376747 
M  I . . . . . . . . . . . . . . . . . . . . 
NiV/MY/BA/2010/MY, 
FN869553 
M  . . . . . . . . . . V  E .  D  . . . . . . . 
NiV/KH/BA/2004/KHM, 
AY858110 
M  . . . . . . . . . . V  E .  D  T . . .  G  P  T 
NiV/BD/HU/2004/1, 
AY988601 
B  . . D . .  . . . N . V E . D . K  D  R .  . T 
NiV/BD/HU/2004/FA,  
JN808858 
B  . . . . . . . .  N  N  V  E  M  D  . K  D  R  . . T 
NiV/BD/HU/2004/RA2, 
JN808861 
B  . . . . . . . .  N  . V  E .  D  . K  D  R  . . T 
NiV/BD/HU/2004/RAJ, 
JN808862 
B  . . . . . . I .  N  . V  E  M  D  . K  D  R  . . T 
NiV/BD/HU/2008/MA, 
JN808857 
B  . . . . . . . .  N  . V  E .  D  . K  D  R  . . T 
NiV/BD/HU/2008/RA, 
JN808863 
B  . . . . . . . .  N  . V  E .  D  . K  D  R  . . T 
NiV/BD/HU/2010/FA1, 
JN808864 
B  . . . . .  . . K  N . V E . D . K  D  R .  . T 
NiV/BD/HU/2010/GO, 
JN808860 
B  . . . . V . . . N . V E . D . K  D  R .  . T 
NiV/BD/HU/2010/FA2, 
JN808859 
B  . . . . . . . .  N  . V  E .  D  . K  D  R  . . T 
NiV/IN/HU/2007/FG, 
FJ513078 
B  . .  . R .  .  .  . N . V E . D . K D  R .  . T 
*Dots indicate sequence identity with AF212302. NiV, Nipah virus; MY, Malaysia; HU, human; G, genotype classification; genotype M, sequences from 
Malaysia  and Cambodia; genotype B, sequences from Bangladesh and India; T, threonine, S, serine; E, glutamate; Q, glutamine; I, isoleucine; M, 
methionine; N, asparagine; R, arginine; D, aspartate; K, lysine; G, glycine; V; valine; P, proline; PI, pig; BA, bat; KH, Cambodia; BD, Bangladesh; IN,  
India. RESEARCH
genes was AAA, and the rest of the intergenic sequences 
were GAA. The biological implications of ﬁ  nding 
adenosine in the ﬁ  rst position of NiV intergenic sequences 
is unknown. The 3′ leader and 5′ trailer sequences of the 
2008 NiV isolates were identical to those found in the 2004 
Bangladesh and 2007 India isolates.
Discussion
From the initial outbreak of NiV in Malaysia until now, 
there has not been a standard method by which to classify 
NiVs. With the accumulation of sequences from subsequent 
human outbreaks in Bangladesh and India, along with an 
increasing number of bat-derived sequences, we propose a 
standardized genotyping method for NiV. The goal behind a 
genotyping scheme is to classify viruses by using a smaller 
sequence window that has levels of sequence variability 
that correspond to variability between complete genomes 
and that would give the same phylogenetic tree topology 
with high bootstrap values. Genotyping schemes for other 
paramyxoviruses, such as measles virus and mumps virus, 
have been delineated (31,32).
Before this study, there has been a growing body of 
partial-sequence data obtained from a 357-nt region coding 
for the COOH-terminus of N (NiV genome positions 1197–
1553) (23,33). Although obtaining sequence information 
from this window has the advantage of tracking more 
variability at the nucleotide and the amino acid levels, 
it could potentially overestimate the level of variability 
between sequences within and across genotypes. Pairwise 
nucleotide sequence comparisons performed by using the 
357-nt window estimate the overall sequence variation 
at ≈8%, whereas the sequence variation of the complete 
N ORF is ≈6% (Table 2; online Technical Appendix 
Figure 1, panels A, D). In particular, the 357-nt window 
overestimates the variability within genotype M of the P. 
vampyrus bat sequence at ≈2%, whereas variability of the 
sequence within genotype M is <1% when the complete 
N ORF is taken into account. The 729-nt window in the 
N terminal region proposed in this study would serve as a 
more conservative scheme for genotyping because it has 
little amino acid variation but has nucleotide variability of 
≈5.5% according to pairwise comparisons between the 2 
proposed genotypes, which only slightly underestimates 
the variability among sequences for the complete N ORF 
(online Technical Appendix Figure 1, panels A, C). As with 
other genotyping schemes that facilitate the classiﬁ  cation 
of viruses, our proposed scheme is amenable to corrective 
measures as warranted by evidence from sequences 
obtained from future outbreaks and bat surveillance studies.
In summary, we conducted a comprehensive 
molecular phylogenetic analysis of currently available 
complete NiV gene ORFs at the nucleotide and amino 
acid levels, including newly obtained sequence data from 
NiV outbreaks in Bangladesh in 2008 and 2010. Analyses 
of the combined sequence data obtained from Bangladesh 
and India in the past decade led us to propose a genotyping 
scheme based on a 729-nt window of the NiV N ORF. This 
genotyping scheme provides a simple and accurate way to 
classify current and future NiV sequences.
M.K.L. was supported by an American Society for 
Microbiology postdoctoral fellowship. Financial support for 
this research came from CDC core funding, ICDDR,B, and 
US National Institutes of Health, grant no. 07-015-0712-52200 
(Bangladesh-NIH/EID).
Dr Lo is a microbiologist with the Viral Special Pathogens 
Branch at CDC. His research interests include the molecular 
pathogenesis and epidemiology of Nipah virus.
References
  1.   Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, et 
al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 
2000;288:1432–5. http://dx.doi.org/10.1126/science.288.5470.1432
  2.   Chua KB. Nipah virus outbreak in Malaysia. J Clin Virol. 2003;
26:265–75. http://dx.doi.org/10.1016/S1386-6532(02)00268-8
  3.   Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, 
et al. Nipah virus–associated encephalitis outbreak, Siliguri, India. 
Emerg Infect Dis. 2006;12:235–40.
  4.   Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, 
Rahman M, et al. Genomic characterization of Nipah virus, West 
Bengal, India. Emerg Infect Dis. 2011;17:907–9.
  5.   Luby SP, Hossain MJ, Gurley ES, Ahmed B-N, Banu S, Khan SU, 
et al. Recurrent zoonotic transmission of Nipah virus into humans, 
Bangladesh, 2001–2007. Emerg Infect Dis. 2009;15:1229–35. 
http://dx.doi.org/10.3201/eid1508.081237
  6.   International Centre for Diarrheal Disease Research. Bangladesh. 
Nipah outbreak in Faridpur District, Bangladesh, 2010. Health and 
Science Bulletin. 2010;8:6–11.
  7.   Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gur-
ley E, et al. Foodborne transmission of Nipah virus, Bangladesh. 
Emerg Infect Dis. 2006;12:1888–94. http://dx.doi.org/10.3201/
eid1212.060732
  8.   Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam 
MR, et al. Person-to-person transmission of Nipah virus in a Bangla-
deshi community. Emerg Infect Dis. 2007;13:1031–7.
  9.   Luby SP, Gurley ES, Hossain MJ. Transmission of human infections 
with Nipah virus. Clin Infect Dis. 2009;49:1743–8. http://dx.doi.
org/10.1086/647951
10.   Lo MK, Rota PA. The emergence of Nipah virus, a highly patho-
genic paramyxovirus. J Clin Virol. 2008;43:396–400. http://dx.doi.
org/10.1016/j.jcv.2008.08.007
11.   Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, 
et al. Genetic characterization of Nipah virus, Bangladesh, 2004. 
Emerg Infect Dis. 2005;11:1594–7.
12.   Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, Rah-
man M, et al. Date palm sap linked to Nipah virus outbreak in Ban-
gladesh, 2008. Vector Borne Zoonotic Dis. 2011; [Epub ahead of 
print]. http://dx.doi.org/10.1089/vbz.2011.0656
13.   Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah and 
Hendra virus infections. Microbes Infect. 2001;3:289–95. http://
dx.doi.org/10.1016/S1286-4579(01)01382-X
254  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 2, February 2012Characterization of Nipah Virus, Bangladesh
14.   Chomczynski P, Sacchi N. Single-step method of RNA isolation 
by acid guanidinium thiocyanate-phenol-chloroform extraction. 
Anal Biochem. 1987;162:156–9. http://dx.doi.org/10.1016/0003-
2697(87)90021-2
15.   Halpin K, Bankamp B, Harcourt BH, Bellini WJ, Rota PA. Nipah 
virus conforms to the rule of six in a minigenome replication assay. 
J Gen Virol. 2004;85:701–7. http://dx.doi.org/10.1099/vir.0.19685-0
16.   Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 
MEGA5: Molecular Evolutionary Genetics Analysis using maxi-
mum likelihood, evolutionary distance, and maximum parsimony 
methods. Mol Biol Evol. 2011;10:2731–9. http://dx.doi.org/10.1093/
molbev/msr121
17.   Ong ST, Yusoff K, Kho CL, Abdullah JO, Tan WS. Mutagenesis of 
the nucleocapsid protein of Nipah virus involved in capsid assembly. 
J Gen Virol. 2009;90:392–7. http://dx.doi.org/10.1099/vir.0.005710-
0
18.   Chan YP, Koh CL, Lam SK, Wang LF. Mapping of domains respon-
sible for nucleocapsid protein-phosphoprotein interaction of Henipa-
viruses. J Gen Virol. 2004;85:1675–84. http://dx.doi.org/10.1099/
vir.0.19752-0
19.   Omi-Furutani M, Yoneda M, Fujita K, Ikeda F, Kai C. Novel phos-
phoprotein-interacting region in Nipah virus nucleocapsid protein 
and its involvement in viral replication. J Virol. 2010;84:9793–9. 
http://dx.doi.org/10.1128/JVI.00339-10
20.   Rodriguez JJ, Cruz CD, Horvath CM. Identiﬁ  cation of the nucle-
ar export signal and STAT-binding domains of the Nipah virus V 
protein reveals mechanisms underlying interferon evasion. J Vi-
rol. 2004;78:5358–67. http://dx.doi.org/10.1128/JVI.78.10.5358-
5367.2004
21.   Shaw ML, Garcia-Sastre A, Palese P, Basler CF. Nipah virus V 
and W proteins have a common STAT1-binding domain yet inhibit 
STAT1 activation from the cytoplasmic and nuclear compartments, 
respectively. J Virol. 2004;78:5633–41. http://dx.doi.org/10.1128/
JVI.78.11.5633-5641.2004
22.   Ciancanelli MJ, Volchkova VA, Shaw ML, Volchkov VE, Basler 
CF. Nipah virus sequesters inactive STAT1 in the nucleus via a P 
gene–encoded mechanism. J Virol. 2009;83:7828–41. http://dx.doi.
org/10.1128/JVI.02610-08
23.   Rahman SA, Hassan SS, Olival KJ, Mohamed M, Chang LY, Has-
san L, et al. Characterization of Nipah virus from naturally infected 
Pteropus vampyrus bats, Malaysia. Emerg Infect Dis. 2010;16:1990–
3.
24.   Ciancanelli MJ, Basler CF. Mutation of YMYL in the Nipah virus 
matrix protein abrogates budding and alters subcellular localization. 
J Virol. 2006;80:12070–8. http://dx.doi.org/10.1128/JVI.01743-06
25.   Patch JR, Han Z, McCarthy SE, Yan L, Wang LF, Harty RN, et al. 
The YPLGVG sequence of the Nipah virus matrix protein is required 
for budding. Virol J. 2008;5:137. http://dx.doi.org/10.1186/1743-
422X-5-137
26.   Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, et al. 
Ubiquitin-regulated nuclear-cytoplasmic trafﬁ   cking of the Nipah 
virus matrix protein is important for viral budding. PLoS Pathog. 
2010;6:e1001186. http://dx.doi.org/10.1371/journal.ppat.1001186
27.   Negrete OA, Chu D, Aguilar HC, Lee B. Single amino acid changes 
in the Nipah and Hendra virus attachment glycoproteins distinguish 
ephrinB2 from ephrinB3 usage. J Virol. 2007;81:10804–14. http://
dx.doi.org/10.1128/JVI.00999-07
28.   Bowden TA, Aricescu AR, Gilbert RJ, Grimes JM, Jones EY, Stuart 
DI. Structural basis of Nipah and Hendra virus attachment to their 
cell-surface receptor ephrin-B2. Nat Struct Mol Biol. 2008;15:567–
72. http://dx.doi.org/10.1038/nsmb.1435
29.   Poch O, Blumberg BM, Bougueleret L, Tordo N. Sequence compari-
son of ﬁ  ve polymerases (L proteins) of unsegmented negative-strand 
RNA viruses: theoretical assignment of functional domains. J Gen 
Virol. 1990;71:1153–62. http://dx.doi.org/10.1099/0022-1317-71-5-
1153
30.  Harcourt BH, Tamin A, Halpin K, Ksiazek TG, Rollin PE, Bellini 
WJ, et al. Molecular characterization of the polymerase gene and ge-
nomic termini of Nipah virus. Virology. 2001;287:192–201. http://
dx.doi.org/10.1006/viro.2001.1026
31.   Rota PA, Featherstone DA, Bellini WJ. Molecular epidemiology 
of measles virus. Curr Top Microbiol Immunol. 2009;330:129–50. 
http://dx.doi.org/10.1007/978-3-540-70617-5_7
32.   Jin L, Rima B, Brown D, Orvell C, Tecle T, Afzal M, et al. Proposal 
for genetic characterisation of wild-type mumps strains: preliminary 
standardisation of the nomenclature. Arch Virol. 2005;150:1903–9. 
http://dx.doi.org/10.1007/s00705-005-0563-4
33.   Wacharapluesadee S, Hemachudha T. Duplex nested RT-PCR 
for detection of Nipah virus RNA from urine specimens of bats. 
J Virol Methods. 2007;141:97–101. http://dx.doi.org/10.1016/j.
jviromet.2006.11.023
Address for correspondence: Michael K. Lo, Centers for Disease Control 
and Prevention, 1600 Clifton Rd, Mailstop G14, Atlanta, GA 30333, USA; 
email: mko2@cdc.gov
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 2, February 2012  255
All material published in Emerging Infectious Diseases is in 
the public domain and may be used and reprinted without 
special permission; proper citation, however, is required.